Commons Clinic operates a vertically integrated, physician-led specialty care platform that unites advanced diagnostics, personalized care pathways, and interventional procedures into a single accountable system. It launched Wholebody by Commons Clinic, a multi-specialty suite that provides comprehensive diagnostics and direct specialist treatments across musculoskeletal, cardiovascular, women’s health, metabolic, orthopedic, gastrointestinal, chronic pain, and preventive oncology care. Each Wholebody patient program includes up to three specialty consults via Commons Clinic’s national expert network and priority placement into a vetted FastPass network of primary care partners for accelerated, contiguous care. The organization emphasizes early detection, tailored prevention, and rapid intervention using technologies such as genetic testing (BRCA), coronary plaque assessment, and multi-cancer screening (Galeri) to create immediate, actionable pathways to treatment. Commons highlights its history of musculoskeletal innovation and plans to extend that playbook across cardiac, metabolic, cancer, and women’s health service lines under physician leadership. The company is based in Los Angeles and uses its vertically integrated model to reduce costs while improving specialty access and outcomes. Commons Clinic operates an integrated health system focused on spine, orthopedics, and pain management, combining physicians, branded care centers, surgical facilities and a native virtual clinic to deliver end-to-end care. Its platform converges value-based care, clinicians, ambulatory facilities and surgical centers to improve the patient experience. The company offers all-inclusive care programs for procedures including total joint replacements and spinal fusions. Founded in 2021 and based in Los Angeles, Commons Clinic raised a $19.5M Series A that brought its total funding to $33.5M. The company intends to use the proceeds to expand operations and broaden its business reach. Leadership includes co-founders Nick Aubin (CEO) and Paulo da Costa (COO); the company also added new board members following the round.

Total raised

$46M

Funding rounds

2

Latest round

Series B

Latest activity

Jun 2025